TYMS and pancreatic ductal adenocarcinoma: However, inhibition of TYMS by 5-FU alone or when combined with other cytotoxic agents in the FOLFIRINOX regimen is consistently associated with induction of TYMS overexpression, resulting in acquired drug resistance in patients with pancreatic ductal adenocarcinoma (PDAC) (1, 18).